<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC_11(10-11)_463-464</article-id>
<article-id pub-id-type="doi">10.15836/ccar2016.463</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Association of chronic kidney disease with periprocedural myocardial injury after elective stent implantation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1650-4735</contrib-id><name><surname>Jerki&#x0107;</surname><given-names>Helena</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1582-1552</contrib-id><name><surname>Stipinovi&#x0107;</surname><given-names>Mario</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3257-110X</contrib-id><name><surname>Po&#x010D;ani&#x0107;</surname><given-names>Darko</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1575-1902</contrib-id><name><surname>Kranj&#x010D;evi&#x0107;</surname><given-names>Stjepan</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7626-3534</contrib-id><name><surname>Kozmar</surname><given-names>Damir</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1229-7983</contrib-id><name><surname>Letilovi&#x0107;</surname><given-names>Tomislav</given-names></name></contrib>
<aff id="aff1">University Hospital Merkur, Zagreb, <country>Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address for correspondence: Helena Jerki&#x0107;, Klini&#x010D;ka bolnica Merkur, Zaj&#x010D;eva 19, HR-10000 Zagreb, Croatia. / Phone: +385-99-4888-576 / E-mail: <email xlink:href="helenajerkic@yahoo.com">helenajerkic@yahoo.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>11</month><year>2016</year></pub-date>
<volume>11</volume>
<issue>10-11</issue>
<fpage>463</fpage>
<lpage>464</lpage>
<history>
<date date-type="received"><day>14</day><month>09</month><year>2016</year></date><date date-type="accepted"><day>10</day><month>10</month><year>2016</year></date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>coronary artery disease</kwd><kwd>chronic kidney disease</kwd><kwd>periprocedural myocardial injury</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Objectives</bold>: Coronary artery disease (CAD) is the leading cause of mortality in patients with chronic kidney disease (CKD). Patients with CKD who undergo coronary revascularization may have more ischemic events than patients without CKD (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). The aim of this study was to determine the incidence and intensity of periprocedural myocardial injury (PMI) after elective stent implantation among patients with and without CKD.</p>
<p><bold>Patients and Methods</bold>: This study prospectively included 344 consecutive patients with stable angina pectoris who underwent an elective PCI at Merkur University Hospital, Zagreb, Croatia, in a period between March 2012 and June 2015 (<xref ref-type="table" rid="t1"><bold>Table 1</bold></xref>). Patients were divided into two groups: control group with estimated glomerular filtration rate (eGFR) &gt; 90 ml/min/1.73m<sup>2</sup> and the CKD group with eGFR &lt; 90 ml/min/1.73m<sup>2</sup>, with further subdivision according to CKD stage. Serum troponin I (cTnI) concentrations were measured at baseline and at 8 and 16 hours after PCI. Periprocedural increase of cTnI above the upper reference limit (URL) was defined as PMI. If cTnI increase &#x2265; 5x URL, it was considered a PMI of high degree, while an increase to &lt; 5x URL was considered a PMI of low degree (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>).</p>
<table-wrap id="t1" position="float">
<label>Table 1</label><caption><title>Baseline characteristics of the study participants.</title></caption>
<table frame="hsides" rules="groups">
<col width="41.91%"/>
<col width="22.96%"/>
<col width="22.97%"/>
<col width="12.16%"/>
<thead>
<tr>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></th>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>eGFR</bold><break/><bold>&gt;90 ml/min/1.73 m<sup>2</sup></bold><break/><bold>(n= 128)</bold></th>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>eGFR</bold><break/><bold>&lt;90 ml/min/1.73m<sup>2</sup></bold><break/><bold>(n= 216)</bold></th>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>p value</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Male, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">102 (79.6)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">140 (64.8)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&lt;0.01</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Age, years</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">59.7 &#x00B1; 8.1</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">67.1 &#x00B1; 10.2</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&lt;0.01</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>BMI&gt;30 kg/m<sup>2</sup> (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">38 (29.6)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">73 (33.7)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.43</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Hypertension, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">112 (87.5)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">201 (93.0)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.08</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Hyperlipidemia (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">107 (83.6)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">186 (86.1)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.64</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Diabetes mellitus, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">38 (29.6)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">83 (38.4)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.10</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Current smoker, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">37 (28.9)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">33 (15.3)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&lt;0.01</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Previous PCI, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">43 (33.6)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">65 (30.1)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.50</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Previous CABG, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">3 (2.3)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">9 (4.1)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.37</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="col"><bold>Medication:</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>ACE inhibitors, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">107 (83.6)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">188 (87.1)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.47</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>ARB, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">11 (8.6)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">22 (10.2)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.62</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Beta blockers, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">110 (85.9)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">177 (81.9)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.50</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Lipid-lowering drugs, n (%)</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">106 (82.8)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">188 (87.1)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">0.23</td>
</tr>
</tbody>
</table><table-wrap-foot>
<p>eGFR = estimated glomerular filtration rate; BMI = body mass index; CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; ACE = angiotensin-converting enzyme; ARB = angiotensin II receptor blocker</p>
</table-wrap-foot></table-wrap>
<p><bold>Results</bold>: There were no significant differences in incidence of PMI between control and CKD group after 8 hours (47.6% vs 44.9%, p=0.62) or after 16 hours (64.8% vs. 61.6%, p=0.55). There were also no significant differences in intensity of PMI between control and CKD group after 8 hours (0.13 &#x00B1; 0.33 vs 0.11 &#x00B1; 0.21, p= 0,58)) or after 16 hours (0.24 &#x00B1; 0.46 vs 0.29 &#x00B1; 0.86, p=0.61). We further assessed incidence and severity of PMI with respect to CKD burden (i.e. CKD stage) and we found no significant differences in the incidence or intensity of PMI 8 and 16 h after PCI in groups according to the eGFR (<xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>, <xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>).</p>
<fig id="f1" position="float" fig-type="figure"><label>Figure 1</label><caption><p>Incidence of periprocedural myocardial injury 8 h after percutaneous coronary intervention according to the estimated glomerular filtration rate.&#x2028;eGFR = estimated glomerular filtration rate; PMI = periprocedural myocardial injury</p></caption><graphic xlink:href="CC_11(10-11)_463-464-f1"></graphic></fig>
<fig id="f2" position="float" fig-type="figure"><label>Figure 2</label><caption><p>Incidence of periprocedural myocardial injury 16 h after percutaneous coronary intervention according to the estimated glomerular filtration rate.&#x2028;eGFR = estimated glomerular filtration rate; PMI = periprocedural myocardial injury</p></caption><graphic xlink:href="CC_11(10-11)_463-464-f2"></graphic></fig>
<p><bold>Conclusion</bold>: We found no association between incidence or intensity of PMI and the presence of CKD. Furthermore, CKD burden (i.e. stratification of patients according to the CKD stage) was also not associated with higher incidence or intensity of PMI after elective PCI.</p>
</body>
<back>
<ref-list>
<title>Literature</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>PB</given-names></name><name><surname>Jeremias</surname><given-names>A</given-names></name><name><surname>Naidu</surname><given-names>SS</given-names></name><name><surname>Brener</surname><given-names>SJ</given-names></name><name><surname>Lima</surname><given-names>F</given-names></name><name><surname>Shlofmitz</surname><given-names>RA</given-names></name><etal/></person-group> <article-title>Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing PCI.</article-title> <source>Catheter Cardiovasc Interv</source>. <year>2012</year>;<volume>80</volume>(<issue>3</issue>):<fpage>352</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/ccd.23394</pub-id><pub-id pub-id-type="pmid">22566286</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thygesen</surname><given-names>K</given-names></name><name><surname>Alpert</surname><given-names>JS</given-names></name><name><surname>Jaffe</surname><given-names>AS</given-names></name><name><surname>Simoons</surname><given-names>ML</given-names></name><name><surname>Chaitman</surname><given-names>BR</given-names></name><name><surname>White</surname><given-names>HD</given-names></name></person-group>. <article-title>Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction; ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction.</article-title> <source>Eur Heart J</source>. <year>2012</year>;<volume>33</volume>(<issue>20</issue>):<fpage>2551</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehs184</pub-id><pub-id pub-id-type="pmid">22922414</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
